Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

LONDON - The World Health Organization plans to officially back the use of weight-loss drugs to ... The wildly popular obesity drugs - Wegovy developed by Novo Nordisk and Zepbound by Eli Lilly ...

The chair of Tesla’s board of directors denied a report that the company had begun to look for a replacement for Elon Musk, ...

The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli ...